Debevoise & Plimpton LLP has advised Access Industries. Goodwin Procter LLP and White & Case LLP, along with Wolf, Greenfield & Sacks, P.C., have advised Disc...
Access Industries Completes Secondary Offering of Disc Medicine Shares
Disc Medicine’s $259.3 Million Follow-on Offering
Goodwin Procter advised Disc Medicine, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the offering. Disc Medicine (NASDAQ: IRON) announced its upsized underwritten...
Janux Therapeutics’ $350 Million Common Stock Offering
Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
Monte Rosa Therapeutics’ $100 Million Underwritten Public Offering
Goodwin Procter advised Monte Rosa Therapeutics, while Paul Hastings advised TD Cowen and Wedbush PacGrow, as joint book-running managers, in the offering. Monte Rosa Therapeutics, Inc....
PepGen’s $108 Million Initial Public Offering
Latham & Watkins represented the underwriters in the IPO while Goodwin advised PepGen. PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with...
Omega Therapeutics’ $144.6 Million IPO
Goodwin Procter advised Goldman Sachs & Co. LLC and the other underwriters on the deal. Omega Therapeutics, Inc. (Nasdaq: OMGA), a development-stage biotechnology company leveraging its OMEGA...